Why precision medicines for oncology demands precision engagement

Life sciences companies overwhelmed with large volumes of information and data available - both in terms of therapies and patient-reported outcomes - must establish a more efficient, bi-directional communication model with care teams to succeed.

The full Med City News article can be viewed at this link.